Kersten Bartelt News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Med record data shows improvements in anxiety and depression in people taking the drugs for either diabetes or obesity.

People taking a popular type of drug for weight loss or to manage diabetes have a decreased likelihood of being newly diagnosed with depression or anxiety, according to an analysis of millions of people’s health records.

Weight loss drugs linked to lower likelihood of depression and anxiety diagnoses, according to a new study.

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglutide is the active ingredient found in Ozempic, which is used for type 2 diabetes, and Wegovy, which ...

WLADIMIR BULGAR/SCIENCE PHOTO LIBRARY/Getty Images(NEW YORK) -- Most weight loss drugs were linked to a lower likelihood of depression and anxiety diagnoses, according to research published by Epic Research. The researchers looked at over three million diabetic patients and nearly one million non-diabetic patients taking GLP-1 medications, which is the class of drugs representing popular name brands such as Ozempic, Wegovy, Zepbound, and Mounjaro in the study that was published Tuesday. Semaglutide is the active ingredient found in Ozempic, which is used for type 2 diabetes, and Wegovy, which ...